TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9718249

Group type: EXPERIMENTAL
Intervention: Epinephrine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attentional focus manipulation
Number of subjects: 0
Study: 7654493

Group type: EXPERIMENTAL
Intervention: Pantoprazole (40 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 2668979

Group type: EXPERIMENTAL
Intervention: Moclobemide 50 mg capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Imipramine 25 mg tablets
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 129494

Group type: EXPERIMENTAL
Intervention: Oral tetracycline (500 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical tetracycline (0.5% solution applied twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31345967

Group type: EXPERIMENTAL
Intervention: Video consent tool
Number of subjects: 20
Study: 27550719

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Resistance training (RT) without TRF
Number of subjects: 0
Study: 26083150

Group type: EXPERIMENTAL
Intervention: MID-ART (Test)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 254
Study: 22684372

Group type: EXPERIMENTAL
Intervention: Isometric ankle dorsi flexion training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Isotonic ankle dorsi flexion training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Isotonic plantar flexion training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Isometric plantar flexion training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: All training exercise protocols
Number of subjects: 26
Study: 21940742

Group type: EXPERIMENTAL
Intervention: New multimodal system (SAFERSleep)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: New multimodal system (SAFERSleep) with key principles applied
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: New multimodal system (SAFERSleep) without key principles applied
Number of subjects: 89
Study: 19532133

Group type: EXPERIMENTAL
Intervention: Wire-guided cannulation technique
Number of subjects: 5

Group type: COMPARATOR
Intervention: Standard cannulation technique
Number of subjects: 5
Study: 17165243

Group type: COMPARATOR
Intervention: Immediate-release nicotinic acid
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Sustained-release nicotinic acid
Number of subjects: 5000
Study: 15233807

Group type: EXPERIMENTAL
Intervention: 50% cyclosporine (CsA) reduction, n = 16
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (continued CsA dose), n = 15
Number of subjects: 31
Study: 11277680

Group type: EXPERIMENTAL
Intervention: Intervention worksites
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control worksites
Number of subjects: 28
Study: 9215121

Group type: EXPERIMENTAL
Intervention: Tyramide enhanced avidin‐biotin immunostaining method
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard avidin‐biotin immunostaining methods
Number of subjects: 19
Study: 8251351

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) patch test
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Mantoux test (tuberculin injection)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control sites (uninvolved skin > 7 cm distant from test sites)
Number of subjects: 15
Study: 3300248

Group type: EXPERIMENTAL
Intervention: Oral sustained-release isosorbide dinitrate (ISDN), 20 to 40 mg twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31374188

Group type: EXPERIMENTAL
Intervention: HIV-positive women on ART
Number of subjects: 38

Group type: COMPARATOR
Intervention: HIV-negative women initiating DMPA
Number of subjects: 38
Study: 28421648

Group type: EXPERIMENTAL
Intervention: Response imagery
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Response imagery with verbal suggestion
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Response imagery only
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control imagery
Number of subjects: 215

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 215
Study: 26641854

Group type: EXPERIMENTAL
Intervention: Body Project intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Educational control condition
Number of subjects: 0
Study: 24165561

Group type: EXPERIMENTAL
Intervention: Intervention arm (HIV prevention trial)
Number of subjects: 4505

Group type: COMPARATOR
Intervention: Control arm (HIV prevention trial)
Number of subjects: 4505

Group type: EXPERIMENTAL
Intervention: Both arms (HIV prevention trial)
Number of subjects: 4505
Study: 20421151

Group type: EXPERIMENTAL
Intervention: Proton beam therapy and capecitabine (825 mg/m² b.i.d. for 10 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Proton beam therapy and capecitabine
Number of subjects: 15
Study: 18653493

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg + Dexamethasone 8 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 16932227

Group type: EXPERIMENTAL
Intervention: Open lung concept (OLC) ventilation with total PEEP of 14 +/- 4 cm H2O
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional ventilation with total PEEP of 5 cm H2O
Number of subjects: 28
Study: 15282656

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Heparin (UFH)
Number of subjects: 100
Study: 11243639

Group type: EXPERIMENTAL
Intervention: Serum bFGF levels in vitiligo patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Suction blister fluid bFGF levels in vitiligo patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls (3 females, 8 males)
Number of subjects: 20
Study: 9068534

Group type: EXPERIMENTAL
Intervention: Right ventricular septal pacing in VDD mode at atrioventricular delays of 100 to 200 ms
Number of subjects: 13

Group type: COMPARATOR
Intervention: Intrinsic rhythm
Number of subjects: 13
Study: 8222739

Group type: EXPERIMENTAL
Intervention: Controlled-release ketoprofen tablets (200 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Indomethacin suppository (100 mg)
Number of subjects: 83
Study: 3100675

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Codeine phosphate 15 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Ibuprofen/codeine combination
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Aspirin 600 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 30982715

Group type: EXPERIMENTAL
Intervention: GR_COPD program
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (patients who declined the GR_COPD program)
Number of subjects: 158
Study: 29530385

Group type: EXPERIMENTAL
Intervention: Pedometer-based step count prescription strategy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pedometer-based monitoring combined with step count prescriptions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Strategies to integrate more steps into routines
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Challenges faced by participants who decreased step counts
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physician-delivered strategy
Number of subjects: 20
Study: 27578294

Group type: EXPERIMENTAL
Intervention: Telephone-based health coaching program (10 sessions)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Information only
Number of subjects: 710
Study: 24469645

Group type: COMPARATOR
Intervention: Conventional treatment (daily hydration of 2500 mL, ciprofloxacin, diclofenac sodium, spasmolytic agent)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Conventional treatment + tamsulosin 0.4 mg orally daily for 4 weeks
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Ureteroscopy
Number of subjects: 127
Study: 21915740

Group type: EXPERIMENTAL
Intervention: PEERS intervention (caregiver-assisted social skills training)
Number of subjects: 0
Study: 20513779

Group type: EXPERIMENTAL
Intervention: High-quality guideline content
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-quality guideline content
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: User's manual of AGREE II
Number of subjects: 30
Study: 18058410

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study: 16101362

Group type: EXPERIMENTAL
Intervention: Surgical periodontal treatments (four different surgical procedures)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (persons without periodontitis)
Number of subjects: 40
Study: 12116341

Group type: EXPERIMENTAL
Intervention: Flow cytometric analysis of neoplastic cases
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control cases
Number of subjects: 167
Study: 10890478

Group type: EXPERIMENTAL
Intervention: HES 130/0.4 (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: HES 200/0.5 (n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 20

Group type: COMPARATOR
Intervention: HES 200/0.5
Number of subjects: 20
Study: 8968446

Group type: EXPERIMENTAL
Intervention: BMY 21,502
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: BMY 21,502 (moderate dementia subgroup)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (moderate dementia subgroup)
Number of subjects: 69
Study: 1453290

Group type: EXPERIMENTAL
Intervention: Group I: 2 grams of Cefazolin IV and abdomino-peritoneal irrigation with saline
Number of subjects: 308

Group type: COMPARATOR
Intervention: Group II: 1 gram of Cefazolin IV and 1 gram in saline irrigation solution
Number of subjects: 308
Study: 6377793

Group type: EXPERIMENTAL
Intervention: Combination of methyldopa/hydrochlorothiazide/amiloride (M/HCT/A)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Methyldopa (M)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Hydrochlorothiazide/amiloride (HCT/A)
Number of subjects: 41
Study: 29893596

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (120,000 IU over 1 week)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (inert pills)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 67
Study: 29644871

Group type: EXPERIMENTAL
Intervention: Intervention teams with a PC representative attending discharge rounds twice a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control teams with unenhanced discharge rounds
Number of subjects: 0
Study: 27470399

Group type: EXPERIMENTAL
Intervention: Curcumin (1g/day for 8 weeks)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 117
Study: 25247517

Group type: EXPERIMENTAL
Intervention: Computerized, interactive decision-support guide and access to prenatal testing with no out-of-pocket expense (n=357)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Usual care as per current guidelines (n=353)
Number of subjects: 710
Study: 23180520

Group type: EXPERIMENTAL
Intervention: RVA pacing
Number of subjects: 65

Group type: COMPARATOR
Intervention: RVOTS pacing
Number of subjects: 65
Study: 20492467

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 18614728

Group type: EXPERIMENTAL
Intervention: Porridge with energy density of 0.5 kcal/g
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Porridge with energy density of 1.0 kcal/g
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Porridge with energy density of 1.5 kcal/g
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3 meals/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 4 meals/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 meals/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All energy densities and feeding frequencies
Number of subjects: 18
Study: 16100179

Group type: EXPERIMENTAL
Intervention: Prefixed equimolar nitrous oxide/oxygen mixture (N2O)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Prefixed equimolar nitrogen and oxygen mixture (control)
Number of subjects: 206
Study: 12427060

Group type: EXPERIMENTAL
Intervention: 12‐hour self‐management program (n = 86)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Tape‐recorded health lectures (n = 74)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Waiting list (n = 72)
Number of subjects: 231
Study: 10094750

Group type: EXPERIMENTAL
Intervention: 90 degrees OATV angle
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 45 degrees OATV angle
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: OATV angles (90, 75, 60, 45 degrees)
Number of subjects: 10
Study: 8949813

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propofol 3.3 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 31823545

Group type: EXPERIMENTAL
Intervention: Trial group (screw implantation via vertebral arch-transverse pathway)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (traditional screw implantation technology)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trial group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 28231824

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with auditory biofeedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vestibular rehabilitation without auditory biofeedback
Number of subjects: 0
Study: 25695341

Group type: EXPERIMENTAL
Intervention: CGM self-efficacy score >80
Number of subjects: 120

Group type: COMPARATOR
Intervention: CGM self-efficacy score ≤80
Number of subjects: 120
Study: 23761651

Group type: EXPERIMENTAL
Intervention: 30 g/d of hazelnuts
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 60 g/d of hazelnuts
Number of subjects: 107

Group type: COMPARATOR
Intervention: No nuts (control group)
Number of subjects: 107
Study: 20422422

Group type: EXPERIMENTAL
Intervention: Hysterectomy plus pelvic lymphadenectomy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 38
Study: 18719630

Group type: EXPERIMENTAL
Intervention: Childhood BMI (kg/m(2))
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Childhood height (cm)
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Tall children with high BMI
Number of subjects: 2802
Study: 15996416

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied three times per week for 16 weeks
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied two times per week for 16 weeks
Number of subjects: 146

Group type: COMPARATOR
Intervention: Baseline AK lesions
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 146
Study: 12861143

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (0.625 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 10653205

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 8843209

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1800 mg/day, timed-release formulation)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 1355585

Group type: EXPERIMENTAL
Intervention: Somatostatin analogues (e.g., octreotide)
Number of subjects: 0
Study: 6711468

Group type: EXPERIMENTAL
Intervention: Rice as the major carbohydrate source
Number of subjects: 8

Group type: COMPARATOR
Intervention: Potato as the major carbohydrate source
Number of subjects: 8
Study: 31368267

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (PCEA, Sufentainil + 0.1% Ropivacaine hydrochloride, 5 µg/mL at L3‐L4 interspace)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acupoint injection of Ropivacaine (0.2%, 1 mL/acupoint at LI4 and SP6)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 80
Study: 29574681

Group type: EXPERIMENTAL
Intervention: Goal-directed haemodynamic therapy (colloid solution, dobutamine, ephedrine, or norepinephrine)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional haemodynamic therapy (extra bolus fluid and ephedrine or norepinephrine)
Number of subjects: 62
Study: 26159058

Group type: EXPERIMENTAL
Intervention: High-intensity (HI; acceleration of all treadmill slips=12m/s(2))
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low-intensity (LO; acceleration of all treadmill slips=6m/s(2))
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Progressively increasing intensity (INCR; acceleration of treadmill slips increasing from 6m/s(2) to 12m/s(2))
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Progressively decreasing intensity (DECR; acceleration of treadmill slips decreasing from 12m/s(2) to 6m/s(2))
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CTRL, n=9)
Number of subjects: 36
Study: 24377663

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation (EMS)
Number of subjects: 11
Study: 22826982

Group type: EXPERIMENTAL
Intervention: Endoscopic injection therapy with diluted epinephrine (group I)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combination therapy of epinephrine and hemoclips (group II)
Number of subjects: 58
Study: 20585051

Group type: EXPERIMENTAL
Intervention: Text-comprehension (TC) training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral-language (OL) training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TC and OL training combined (COM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study: 18506129

Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (PLC) therapy at a dosage of 1,200 mg PLC in 250 cc of physiological solution for 5 days a week for 4 weeks
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (PLC) in association with pulsed muscular compression therapy (Vascupump) for 5 sessions a week for 4 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Pulsed muscular compression therapy (Vascupump) only
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Quality of life questionnaire
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Instrumental parameters (CT and Winsor index)
Number of subjects: 42
Study: 15898936

Group type: EXPERIMENTAL
Intervention: Systemic amoxicillin plus metronidazole and CHX irrigation
Number of subjects: 35

Group type: COMPARATOR
Intervention: Subgingival scaling without adjunctive therapy (control group)
Number of subjects: 35
Study: 12918613

Group type: EXPERIMENTAL
Intervention: Non-linear amplification with fast time constants
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Amplified condition
Number of subjects: 50

Group type: COMPARATOR
Intervention: Unaided condition
Number of subjects: 50
Study: 10497771

Group type: EXPERIMENTAL
Intervention: Cover gowns and shoe covers worn by caregivers
Number of subjects: 40

Group type: COMPARATOR
Intervention: No covers worn by caregivers
Number of subjects: 40
Study: 8983866

Group type: EXPERIMENTAL
Intervention: High fat meal with insulin (peak insulin 86.1 ± 10.1 m-units/l)
Number of subjects: 9

Group type: COMPARATOR
Intervention: High fat meal alone
Number of subjects: 9
Study: 1682521

Group type: EXPERIMENTAL
Intervention: Apraclonidine hydrochloride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6959168

Group type: EXPERIMENTAL
Intervention: 10 mg of methadone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Inert placebo
Number of subjects: 9
Study: 31881956

Group type: EXPERIMENTAL
Intervention: Guided-care
Number of subjects: 1541

Group type: EXPERIMENTAL
Intervention: Guided-care (with gene-drug interactions)
Number of subjects: 1541

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 1541
Study: 29417694

Group type: EXPERIMENTAL
Intervention: Duloxetine (DLX, 60 mg once daily)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 26460570

Group type: EXPERIMENTAL
Intervention: Naltrexone (NAL)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Naltrexone (NAL) and prolonged exposure (PE)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 165

Group type: COMPARATOR
Intervention: Pill placebo and PE
Number of subjects: 165
Study: 25077896

Group type: EXPERIMENTAL
Intervention: Active cuff management during cooling and warming (cuff pressure monitored and adjusted)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Passive monitoring (cuff pressure monitored but not adjusted)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Active cuff management
Number of subjects: 24

Group type: COMPARATOR
Intervention: Passive monitoring
Number of subjects: 24
Study: 22689187

Group type: EXPERIMENTAL
Intervention: Totally thoracoscopic repair of VSDs
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional VSD closure through sternotomy
Number of subjects: 36
Study: 19719472

Group type: EXPERIMENTAL
Intervention: WBC‐kit
Number of subjects: 68

Group type: COMPARATOR
Intervention: AUTO‐kit
Number of subjects: 68
Study: 18590940

Group type: EXPERIMENTAL
Intervention: 4-week arginine, proline, glutamate and aspartate-free diet (APF diet)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Complete amino acid diet (control diet)
Number of subjects: 10
Study: 15801505

Group type: EXPERIMENTAL
Intervention: Elaborated words (treatment group)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Non-elaborated words (treatment group)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 57
Study: 12616734

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (FL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amitriptyline (AM)
Number of subjects: 60
Study: 10393518

Group type: EXPERIMENTAL
Intervention: Tretinoin emollient cream, 0.05% (Renova) used nightly in conjunction with daytime usage of one of two 8% glycolic acid lotions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant use of effective moisturizers, mild cleansers, and daily sunscreens with tretinoin.
Number of subjects: 0